Abstract:Objective:To explore the significance of laboratory parameters in predicting the endoscopic manifestations of ulcerative colitis (UC) after treatment.Methods:From January 2015 to December 2020, the clinical data of 68 patients with UC hospitalized and treated in Peking University People′s Hospital were retrospectively and continuously collected. According to the degree of bleeding, vascular pattern, erosion and ulcer under endoscopy before and after treatment, they were divided into progressive group (post-treatment ulcerative colitis endoscopic index of severity (UCEIS) score higher than pre-treatment) and non-progressive group (post-treatment UCEIS score equal to or lower than pre-treatment). The baseline platelet count, platelet volume, platelet hematocrit, platelet distribution width, serum albumin, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and related laboratory parameters were compared between the two groups. And analyzed the significance of related laboratory indexes in predicting the endoscopic manifestations of UC after treatment. Independent sample t test and receiver operating characteristic curve (ROC) analysis were used for statistical analysis. Results:According to the degree of bleeding under endoscopy before and after treatment, the patients were divided into progressive group (12 cases) and non-progressive group (56 cases). The baseline platelet count and platelet volume of the progressive group were higher than those of the non-progressive group ((375.58±154.30) ×10 9/L vs. (288.22±103.76) ×10 9/L, (9.29±1.13) fL vs.(8.52±1.29) fL), and the differences were statistically significant ( t=2.40 and 2.08, P=0.019 and 0.049). According to the degree of vascular texture under endoscopy before and after treatment, the baseline platelet volume and serum albumin level of the progressive group (9 cases) were higher than those of the non-progressive group (59 cases) ((9.58±1.18) fL vs. (8.54±1.26) fL, (41.49±5.08) g/L vs. (36.63±6.14) g/L), and the baseline CRP of the progressive group was lower than that of the non-progressive group (2.26 mg/L(0.95 mg/L) vs.8.64 mg/L (26.08 mg/L) ), and the differences were statistically significant ( t=2.32, 2.32, and z=-2.27, P=0.022, 0.047 and 0.045). According to the degree of erosion and ulcer under endoscopy before and after treatment, CRP and ESR of the progressive group (16 cases) were lower than those of the non-progressive group (52 cases) ((2.21 mg/L(5.26 mg/L) vs. 10.63 mg/L(29.97 mg/L), 14.50 mm/1 h (15.25 mm/1 h) vs.17.00 mm/1 h (11.00 mm/1 h)), and the differences were statisticaly significant ( z=-3.64 and -2.42, P=0.001 and 0.020). The cutoff value of baseline platelet count to assess the progression of bleeding under endoscopy after treatment was 336×10 9/L (sensitivity=0.636, specificity=0.852, area under the curve=0.698). The cutoff value of baseline CRP to assess the progression of erosion and ulcer under endoscopy after treatment was 3.44 mg/L (sensitivity=0.750, specificity=0.727, area under the curve=0.727). Conclusions:The baseline platelet volume, serum albumin and ESR are suggestive of endoscopic mucosal changes in patients with UC after treatment. The baseline platelet count and CRP can predict the efficacy in patients with UC.

Assessment of platelet activation in active ulcerative colitis

Clinical Research of Platelet Activation in Ulcerative Colitis

Platelets can reflect the severity of Crohn's disease without the effect of anemia.

Relationship and Significance Between Anti-Beta 2-Glycoprotein I Antibodies and Platelet Activation State in Patients with Ulcerative Colitis

[Relations of Ulcerative Colitis to Anti-Beta2-glycoprotein Antibodies and to Platelet Activation Status].

P151 Characterization of platelet activation profile in Inflammatory Bowel Disease

Platelet activation through CD62P and the formation of platelet–monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis

Study on Clinical Characteristics and Platelet Function in Ischemic Colitis

Platelet Activity in the Pathophysiology of Inflammatory Bowel Diseases

Relationship between ulcerative colitis and the levels of platelet activation in serum and effect of tanshinon treatment on them

Abnormal Function of Platelets and Role of Angelica Sinensis in Patients with Ulcerative Colitis.

Role of coagulation function tests and hypercoagulation status in patients with ulcerative colitis

Examination and Clinical Significance of Combination Rate Between Beta2-Glycoprotein Ⅰ and Platelet in the Ulcerative Colitis Patients

Clinical significance of expression of peroxisome proliferator-activated receptor γ coactivator 1α in the inflamed mucosa of patients with inflammatory bowel disease

Influence of altered coagulation and fibrinolysis status on disease activity of inflammatory bowel disease

Activation of Platelet NLRP3 Inflammasome in Crohn's Disease

The value of laboratory parameters in predicting endoscopic manifestations of ulcerative colitis after treatment

Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis

Effects and Clinical Significance of Angelica Sinensis Injection on the Functional State of Platelet in Patients with Ulcerative Colitis

Identification and validation of coagulation and fibrinolytic-related diagnostic biomarkers for ulcerative colitis by bioinformatics analysis

Study of the activiation of IL-6 in patients with ulcerative colitis